Ligand Pharmaceuticals
LGND
LGND
211 hedge funds and large institutions have $1.1B invested in Ligand Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 66 increasing their positions, 74 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.07% less ownership
Funds ownership: 87.12% → 87.05% (-0.07%)
11% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 74
Holders
211
Holding in Top 10
1
Calls
$4.15M
Puts
$500K
Top Buyers
| 1 | +$14.9M | |
| 2 | +$9.6M | |
| 3 | +$7.92M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$6.61M |
| 5 |
BlackRock
New York
|
+$3.6M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$7.55M | |
| 3 | -$5.89M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$4.8M |
| 5 |
Impax Asset Management Group
London,
United Kingdom
|
-$2.94M |